| Literature DB >> 29538308 |
Yugal Kishore Mohanta1, Debasis Nayak2, Kunal Biswas3, Sameer Kumar Singdevsachan4, Elsayed Fathi Abd Allah5, Abeer Hashem6, Abdulaziz A Alqarawi7, Dhananjay Yadav8, Tapan Kumar Mohanta9.
Abstract
The present study demonstrates an economical and eco-friendly method for the synthesis of silver nanoparticles (AgNPs) using the wild mushroom Ganoderma sessiliforme. The synthesis of AgNPs was confirmed and the products characterized by UV-visible spectroscopy, dynamic light scattering spectroscopy and X-ray diffraction analysis. Furthermore, Fourier transform infrared spectroscopy (ATR-FTIR) analysis was performed to identify the viable biomolecules involved in the capping and active stabilization of AgNPs. Moreover, the average sizes and morphologies of AgNPs were analyzed by field emission scanning electron microscopy (FE-SEM). The potential impacts of AgNPs on food safety and control were evaluated by the antimicrobial activity of the synthesized AgNPs against common food-borne bacteria, namely, Escherichia coli, Bacillus subtilis, Streptococcus faecalis, Listeria innocua and Micrococcus luteus. The results of this study revealed that the synthesized AgNPs can be used to control the growth of food-borne pathogens and have potential application in the food packaging industry. Moreover, the AgNPs were evaluated for antioxidant activity (aDPPH), for biocompatibility (L-929, normal fibroblast cells), and for cytotoxic effects on human breast adenosarcoma cells (MCF-7 & MDA-MB231) to highlight their potential for use in a variety of bio-applications.Entities:
Keywords: Ganoderma sessiliforme; antimicrobial activity; food borne bacteria; silver nanoparticles
Mesh:
Substances:
Year: 2018 PMID: 29538308 PMCID: PMC6017452 DOI: 10.3390/molecules23030655
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1(A) G. sessiliforme; (B) G. sessiliforme mycelial extract and AgNO3; (C) synthesized silver nanoparticles (AgNPs).
Figure 2The ultraviolet-visible spectra of silver nanoparticles (AgNPs).
Figure 3(A) Size distribution of synthesized AgNPs; (B) Zeta potential of synthesized AgNPs by DLS analysis.
Figure 4ATR-fourier-transformed infrared spectroscopy analysis of silver nanoparticles (AgNPs) and the aqueous extracts of G. sessiliforme.
Figure 5X–ray diffraction analysis of silver nanoparticles (AgNPs) synthesized by the aqueous extracts of G. sessiliforme.
Figure 6Morphological characterization through FE–SEM (A) and HR–TEM (B) microscopy of silver nanoparticles (AgNPs) synthesized by the aqueous extracts of G. sessiliforme; (i)Free standing AgNPs observed in HR–TEM; (ii) analysis of grain diameter of a single AgNP in HR–TEM.
Qualitative phytochemical screening of aqueous extract of G. sessiliforme.
| Phytoconstituent | Observation |
|---|---|
| Alkaloids | − |
| Tannins and phenolic compounds | +++ |
| Glycoside | − |
| Flavonoids | +++ |
| Steroids and sterols | − |
| Triterpenoids | + |
| Sugars | +++ |
| Proteins | +++ |
Notes: +++: Highly present; +: Less present; −: Absent.
Quantitative phytochemical constituents of aqueous extract of G. sessiliforme.
| Phytochemical Constituent | mg/100 g Dry Weight (Mean ± SD) |
|---|---|
| TPC | 620.67 ± 28.00 |
| TFC | 845.26 ± 24.20 |
Figure 7Antioxidant potentials of AgNPs and ascorbic acid (DPPH radical scavenging).
Antimicrobial activity of AgNPs by agar-well diffusion method.
| Mean Zone of Inhibition ± SD (in mm) | |||
|---|---|---|---|
| Name of The Test Strain | Silver Nanoparticles (500 µg/mL) | Kanamycin (5 mg/mL) | DMSO (5%) |
| 11 ± 0.50 | 20.8 ± 0.59 | 0 | |
| 20 ± 1.00 | 13.3 ± 0.12 | 0 | |
| 16 ± 1.00 | 11.1 ± 0.13 | 0 | |
| 22 ± 1.15 | 12.3 ± 0.21 | 0 | |
| 21 ± 1.15 | 10.2 ± 0.31 | 0 | |
Figure 8Antibacterial activities of AgNPs synthesized by G. sessiliforme (volume-50 µL/well): (A) M. luteus; (B) L. innocua; (C) B. subtilis; (D) S. faecalis; (E) E. coli.
Antimicrobial activity of AgNPs by micro broth dilution method.
| Antibacterial Activity of AgNPs (Percentage of Inhibition (%) ± SD) | ||||||
|---|---|---|---|---|---|---|
| Name of The Test Strain | 1000 µg/mL | 500 µg/mL | 250 µg/mL | 125 µg/mL | 61.25 µg/mL | IC50 (µg/mL) |
| 83.10 ± 0.08a | 62.47 ± 0.26b | 40.33 ± 0.21c | 36.33 ± 0.09d | 35.33 ± 0.09e | 338.39 ± 1.71 | |
| 99.53 ± 0.29a | 99.44 ± 0.26a | 99.13 ± 0.17a | 71.47 ± 0.21b | 20.37 ± 1.33c | 93.38 ± 0.70 | |
| 94.63 ± 0.39a | 92.80 ± 0.24b | 60.90 ± 0.22c | 46.03 ± 0.12d | 34.67 ± 0.37e | 150.40 ± 1.00 | |
| 93.93 ± 0.87a | 94.17 ± 0.12a | 80.20 ± 0.22b | 60.20 ± 0.08c | 35.03 ± 0.25d | 94.38 ± 0.25 | |
| 94.27 ± 0.12a | 93.70 ± 0.22b | 70.27 ± 0.12c | 55.33 ± 0.08d | 32.30 ± 0.16e | 106.55 ± 0.32 | |
The data are expressed as a percentage inhibition of bacteria and represent the mean ± SD (n = 3). Antimicrobial activity: exponentially growing cells were treated with different concentrations of AgNPs for 24 h and cell growth inhibition was analyzed through broth dilution assay. In each row, mean values followed with different superscripts significantly differ from each other according to Duncan’s Multiple Range Test (p < 0.05). IC50 is defined as the concentration, which results in a 50% reduction in cell numbers as compared with that of the control cultures (AgNPs). The values represent the mean ± SD of three individual observations.
Figure 9Cytotoxic effect of silver nanoparticles (AgNPs) on L-929 normal fibroblast cell lines.
Figure 10Cytotoxic effect of silver nanoparticles (AgNPs) on: (A) MCF-7; (B) MDA-MB-231 human breast cancer cells.